February 2, 2012

Medicare Part D plans that had incorporated Walgreens into their network gained market share last year, while those without Walgreens collectively lost market share, according to a Walgreens statement issued Wednesday.

January 31, 2012

The Food and Drug Administration has approved a generic drug for anxiety made by Hi-Tech Pharmacal, the drug maker said Tuesday.

January 31, 2012

For every dollar spent on over-the-counter medicines, the U.S. healthcare system realizes a savings of between $6 and $7, or $102 billion all told, the Consumer Healthcare Products Association announced Tuesday with the release of this new study, "The Value of OTC Medicine to the United States."

January 30, 2012

Two groups representing the retail pharmacy industry are urging the federal government to provide guidance to the states on how to adjust Medicaid dispensing fees to determine pharmacy reimbursement.

January 27, 2012

The New England Journal of Medicine on Thursday published an op-ed online that called for more rule-making to govern dietary supplements in an effort to rein in the criminal activity of illicit prescription drug manufacturers that openly disregard the laws currently in effect.

January 20, 2012

One analysis report after another seems to confirm that the generic drug market is in for a huge shift as the number of blockbuster drugs losing patent protection is set to dwindle over the next several years. A recent report by Frost & Sullivan seems to confirm that sentiment.

January 19, 2012

The National Community Pharmacists Association is calling for the Centers for Medicare and Medicaid Services to allow senior patients to enroll in a new Medicare Part D prescription drug plan via a special enrollment period, particularly if patients believe that "material misrepresentations" led them to sign up for a "preferred network" plan with inadequate pharmacy access.

January 10, 2012

In a bipartisan effort, Sens. Kent Conrad, D-N.D., and Olympia Snowe, R-Maine, along with 12 of their colleagues, have expressed concerns with draft Federal Upper Limits lists for Medicaid generic drug reimbursement that recently have been published by the Centers for Medicare and Medicaid Services.

January 9, 2012

CVS Caremark has entered into a definitive agreement to purchase the stand-alone Medicare Part D prescription drug plan business from Health Net for approximately $160 million in cash.

January 6, 2012

RetireSafe, a 400,000-supporter strong grassroots organization that advocates and educates on behalf of America's seniors on issues regarding Social Security, Medicare, health and financial well-being, on Friday issued a press release urging Express Scripts to return to the negotiating table and come to an agreement with Walgreens.

January 3, 2012

Geisinger Health System may be the largest employer to discriminate against a declining minority — smokers — beginning Feb. 1.

December 19, 2011

One-in-eight Americans didn't fill prescriptions last year because they couldn't afford to, but despite difficulties with the economy, that proportion remained level, according to a new study conducted by the Center for Studying Health System Change and funded by the Robert Wood Johnson Foundation.

December 15, 2011

The National Association of Chain Drug Stores and National Community Pharmacists Association issued a statement on Thursday announcing that they commend Reps. Bruce Braley, D-Iowa; Mike Rogers, R-Mich.; and 38 of their colleagues who expressed concerns with draft Federal Upper Limits lists that recently have been published by the Centers for Medicare and Medicaid Services.

December 12, 2011

Following months of meetings and negotiations with the drug and chemical industries, the Food and Drug Administration has released a draft of the goals of the Generic Drug User Fee Act.

December 8, 2011

The Generic Pharmaceutical Association has appointed a new executive who will help guide the organization's newly created research and education institute.

December 5, 2011

Bankrupt grocer A&P has announced that the Locals of the United Food and Commercial Workers International Union have ratified modifications to the collective bargaining agreements with the company — a key step toward completing the company’s financial restructuring.

December 5, 2011

Following the settlement of a patent-litigation suit with Swiss drug maker Novartis over the patch Vivelle-Dot (estradiol transdermal system), a drug for treating symptoms of menopause, Mylan said it had received a patent license to begin selling its version of the drug in December 2013.


December 1, 2011

Generic drug maker Mylan and a partnering company are challenging the patent on a contraceptive drug.

November 28, 2011

The Obama administration confirmed last week that Centers for Medicare and Medicaid Services administrator Donald Berwick will step down from his post on Dec. 2.

November 28, 2011

The Food and Drug Administration last week took legal action against the dietary supplement manufacturer ATF Fitness Products for substituting ingredients and products without noting the changes on the final product labels.

November 22, 2011

The recent approval of a 10% reimbursement rate cut in California’s Medicaid program, known as Medi-Cal, by the Centers for Medicare and Medicaid Services has prompted provider groups to file a lawsuit against the California Department of Healthcare Services and the U.S. Department of Health and Human Services, alleging that the cuts did not follow proper legal channels.

November 21, 2011

Many so-called restricted-network Medicare Part D prescription drug plans don't give adequate pharmacy access to rural residents and are deceptively marketed to patients, the National Community Pharmacists Association said Monday.

November 17, 2011

Pharmacy benefit manager SXC Health Solutions is buying PBM service company HealthTrans for $250 million, SXC said Thursday.

November 15, 2011

The generic drug lobby is stepping up its efforts to persuade the congressional super committee to avoid adopting rules that would ban some patent settlements between branded and generic drug makers.